#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12360	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2185	562.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1455	1455	C	713	C	675	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22282	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3647	609.3	0	.	n	.	0	T695C	SNP	695	695	T	1009	1009	C	639	C,T	601,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22282	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3647	609.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1651	1651	A	709	A	676	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22282	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3647	609.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2285	2285	C	750	C,T	703,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22282	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3647	609.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2911	2911	T	701	T,C	663,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22282	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3647	609.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2359	2359	A	725	A	697	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1620	folP	855	855	100.0	folP.l15.c30.ctg.1	1551	104.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1015	1017	AGC	166;165;166	A;G;C	152;151;151	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	4118	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3524	116.6	1	SNP	p	S91F	1	.	.	271	273	TTC	663	665	TTC	137;139;139	T;T;C	125;127;128	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	4118	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3524	116.6	1	SNP	p	D95N	0	.	.	283	285	GAC	675	677	GAC	140;138;138	G;A;C	127;125;126	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	4118	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3524	116.6	1	SNP	p	D95G	0	.	.	283	285	GAC	675	677	GAC	140;138;138	G;A;C	127;125;126	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1432	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1392	102.0	1	SNP	p	G45D	1	.	.	133	135	GAC	562	564	GAC	183;181;181	G;A;C	170;168;169	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	654	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1118	58.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4288	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2964	144.2	1	SNP	p	D86N	0	.	.	256	258	GAC	578	580	GAC	176;175;175	G;A;C	168;165;165	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4288	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2964	144.2	1	SNP	p	S87W	0	.	.	259	261	AGT	581	583	AGT	175;176;173	A,C;G;T	163,1;166;165	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4288	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2964	144.2	1	SNP	p	S87I	0	.	.	259	261	AGT	581	583	AGT	175;176;173	A,C;G;T	163,1;166;165	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4288	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2964	144.2	1	SNP	p	S87R	0	.	.	259	261	AGT	581	583	AGT	175;176;173	A,C;G;T	163,1;166;165	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	4288	parC	2304	2304	99.78	parC.l15.c30.ctg.1	2964	144.2	1	SNP	p	S88P	0	.	.	262	264	TCC	584	586	TCC	175;176;176	T;C,G;C	166;169,1;168	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3302	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2614	125.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1581	1583	GGC	179;177;174	G;G;C	164;162;159	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1186	1188	GCA	183;187;191	G;C;A	169;174;176	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1189	1191	ATC	193;193;192	A;T,A;C	177;177,1;180	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1201	1203	GTG	195;195;195	G;T;G	181;182;183	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1201	1203	GTG	195;195;195	G;T;G	181;182;183	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1705	1707	ACC	180;179;180	A;C;C	159;162;162	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1759	1761	GCG	161;157;155	G;C;G	138;123;126	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1759	1761	GCG	161;157;155	G;C;G	138;123;126	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1882	1884	AGC	120;118;118	A;G;C	115;112;111	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1891	1893	GGC	109;110;110	G;G;C	103;105;103	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	3200	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2489	127.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1909	1911	CCG	100;101;102	C,G;C;G	71,4;73;75	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4884	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3172	153.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1660	1662	CCG	183;183;181	C,A;C;G	168,1;171;164	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1784	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1830	97.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	333	335	GGC	125;126;128	G;G;C	115;115;116	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1784	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1830	97.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	515	515	C	104	C	100	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	840	842	GGA	203;204;207	G;G;A	191;193;191	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	0	.	p	.	0	.	INDELS	629	630	AA	1043	1045	TAG	222;220;216	T;A;G	214;212;203	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1047	1050	CAAT	212;214;212;214	C;A;A;T	198;205;203;205	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1052	1052	T	215	T	208	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	1	SNP	p	G120K	0	.	.	358	360	GGT	771	773	GGT	231;231;228	G;G;T	215;215;211	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	1	SNP	p	A121D	0	.	.	361	363	GCC	774	776	GCC	225;223;226	G;C;C	210;211;211	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2562	porB1b	1035	1035	98.94	porB1b.l15.c4.ctg.1	1599	159.3	1	SNP	p	A121N	0	.	.	361	363	GCC	774	776	GCC	225;223;226	G;C;C	210;211;211	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9294	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4888	189.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	972	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1187	81.7	1	SNP	p	V57M	1	.	.	169	171	ATG	606	608	ATG	202;204;204	A;T;G	189;189;186	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
